• No results found

Simultaneous bilateral aqueous misdirection following certolizumab therapy for rheumatoid arthritis

N/A
N/A
Protected

Academic year: 2022

Share "Simultaneous bilateral aqueous misdirection following certolizumab therapy for rheumatoid arthritis"

Copied!
3
0
0

Laster.... (Se fulltekst nå)

Fulltekst

Referanser

RELATERTE DOKUMENTER

Objectives: To investigate the long-term effect (week 16) of a 4-week rehabilitation programme for patients with rheumatoid arthritis (RA) and to compare the effect of this

Comparative analysis of disease activity measures, use of biologic agents, body mass index, radiographic features, and bone density in psoriatic arthritis and rheumatoid

The EURIDISS study is an inception cohort that specifi cally included patients with >5 and <10 years of disease duration and, as death in RA has been found to be increased

Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis: Associations to future good radiographic and physical outcomes

Introduction Disease activity in patients with rheumatoid arthritis (RA) is associated with increased cardiovascular morbidity and mortality, of which N-terminal pro-brain

MG patients have an increased risk for complicating autoimmune diseases, most commonly autoimmune thyroid disease, systemic lupus erythematosus and rheumatoid arthritis.. In

Measures of fatigue: Bristol Rheu- matoid Arthritis Fatigue Multi-Dimensional Questionnaire (BRAF MDQ), Bristol Rheumatoid Arthritis Fatigue Numerical Rating Scales (BRAF NRS)

Measures of fatigue: Bristol Rheu- matoid Arthritis Fatigue Multi-Dimensional Questionnaire (BRAF MDQ), Bristol Rheumatoid Arthritis Fatigue Numerical Rating Scales (BRAF NRS)